Thu.Jun 30, 2022

article thumbnail

Why Oncology Pharmacists Should Be at the Helm of Precision Medicine in Oncology

Pharmacy Times

Andre Harvin, PharmD, MS, executive director of Pharmacy, Oncology Services at Cone Health, discusses the importance of putting precision medicine programs into oncology practices with pharmacists leading the way.

130
130
article thumbnail

Biotech spotlight: Twist Bioscience aims to remove limits on drug discovery with DNA synthesis platform

PharmaVoice

As ‘the Amazon of DNA,’ Twist CSO, Aaron Sato, discusses the company’s breakthrough approach to DNA production and its expansion into drug development.

134
134
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Novel C. Difficile Treatment Reduces Recurrence in Key Subgroups

Pharmacy Times

Paul Feuerstadt, MD, FACG, AGAF, discussed research into the novel C. difficile treatment RBX2660 and what investigators have found about its efficacy in key subgroup analyses.

123
123
article thumbnail

Merck launches accelerator programme for AI startups

pharmaphorum

Merck & Co is looking for startup companies applying artificial intelligence , machine-learning and other digital approaches to drug discovery and development for a new accelerator programme. The big pharma – known as MSD outside North America – is initially offering support to 12 companies though the newly-formed Merck Digital Sciences Studio (MDSS) and is now taking applications from would-be participants.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Addressing the Mystery of Long Hauler COVID: The Time is Now

Pharmacy Times

As we learn more about inflammatory syndromes, we may get better at using laboratory tests to identify and isolate the actual cellular and chemical processes that drive them.

123
123
article thumbnail

FDA rejection of Spero’s tebipenem ‘raises resistance threat’

pharmaphorum

The FDA’s decision not to approve Spero Therapeutics’ oral antibiotic tebipenem Hbr for adults with complicated urinary tract infections (cUTI) further increases the threat of antibiotic resistance, according to a GlobalData analyst. The FDA delivered a blow to Spero’s hopes of bringing the carbapenem to market in a complete response letter (CRL) delivered this week, which said another trial would be required to support approval.

FDA 119

More Trending

article thumbnail

Pfizer, BioNTech enter $3.2bn deal with US government for Covid-19 shots

Pharmaceutical Technology

Pfizer and BioNTech have entered a new vaccine supply agreement worth $3.2bn with the US government to supply further doses of their Covid-19 vaccine. As per the agreement, the government will procure 105 million 3µg, 10 µg and 30 µg doses of the vaccine. This deal might comprise Omicron-adapted Covid-19 vaccines for use in adults, contingent on obtaining the US Food and Drug Administration (FDA) authorisation.

article thumbnail

Call to Action: Investigation of Metformin as Adjunctive Therapy to Immunotherapies in Non-Small Cell Lung Cancer

Pharmacy Times

Metformin has been shown to decrease pro-inflammatory cytokines that appear to improve the immune response to tumor cells and improve the efficacy of immunotherapy.

article thumbnail

Neglected tropical diseases: non-profits lead the way as private sectors lags

Pharmaceutical Technology

Stagnating interest from private players and added pressure due to the Covid-19 pandemic has put the onus on academia and non-profits to drive new therapies for neglected tropical diseases (NTDs). New therapies and repurposed assets, could bring conditions like African trypanosomiasis closer to near extinction. Nonprofits like the Drugs for Neglected Diseases initiative (DNDi) and independent researchers are studying diseases such as river blindness, which are missing more targeted and effective

article thumbnail

Pharmacy Focus: Public Health Matters- BONUS Episode for PRIDE Month!

Pharmacy Times

There have been many changes made in the LGBTQ+ community for the better, but there is still work to do be done, especially as a health care professional.

123
123
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

HDT Bio receives Emergency Use Approval for Covid-19 vaccine in India

Pharmaceutical Technology

HDT Bio has received Emergency Use Approval from Indian regulators for its Covid-19 vaccine, Gemcovac. The vaccine leverages self-amplifying RNA (saRNA), which can replicate itself after administration and could be effective at very low doses. As against other existing messenger ribonucleic acid (mRNA) vaccines that need ultra-cold storage, the Gemcovac vaccine is stable at refrigerator temperatures.

article thumbnail

Expert Discusses Long-Term Implications of Roe V. Wade Decision for Pharmacists, Contraception Access

Pharmacy Times

With many ambiguous policies, pharmacists should refer to their State Boards of Pharmacy for guidance and should consider HIPAA implications.

HIPAA 123
article thumbnail

From trial design for patients to trial design with patients: a key topic at DIA ’22

pharmaphorum

At the 2022 Drug Information Association (DIA) annual meeting last week, it was inspiring to connect with fellow research and development (R&D) stakeholders, regulators, health and digital data partners and more to navigate challenges in drug development that impact patients globally. As an industry, we recognise patients as partners in the development process, but if we aim to enhance the patient experience in clinical trials and ultimately, improve patients’ lives, we need to continue to c

article thumbnail

Olaparib, Abiraterone Improves Radiographic Progression-Free Survival in Patients With Metastatic Castration-Resistant Prostate Cancer

Pharmacy Times

Median radiographic progression-free survival was 24.8 months for olaparib plus abiraterone, compared to 16.6 months in the abiraterone arm.

123
123
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Eczac?ba?? to acquire Turkish pharma company Gensenta for $135m

Pharmaceutical Technology

The Eczac?ba?? Group has entered an agreement for the acquisition of a 99.96% stake in Turkish pharmaceutical company Gensenta from Amgen, in a deal worth $135m. Eczac?ba?? is the founder of the first modern pharmaceutical facility in Turkey. With the takeover of Gensenta, Eczac?ba?? will move a step closer to becoming a key healthcare player in Turkey and global markets.

article thumbnail

Clinical Overview: Rivaroxaban (Xarelto) for Multiple Cardiovascular Conditions

Pharmacy Times

Rivaroxaban is the only FDA-approved anticoagulant used in patients with peripheral artery disease and coronary artery disease.

FDA 123
article thumbnail

Lilly enlists Sidekick for breast cancer digital therapeutic

Outsourcing Pharma

The pharmaceutical firm will work with the health tech company to create a digital therapeutic intended for patients dealing with a breast cancer diagnosis.

59
article thumbnail

Disease Factors Influencing Treatment Pathways For HR+/HER2- Advanced Breast Cancer

Pharmacy Times

Dr Ryan Haumschild, PharmD, MS, MBA, leads a discussion focused on HR-positive, HER2-negative treatment in advanced-stage breast cancer.

132
132
article thumbnail

Erectile Dysfunction or Performance Anxiety?

Compounding Pharmacy of America

Understanding the differences between erectile dysfunction and performance anxiety is necessary because it helps you to better identify which one you are experiencing. Again, both conditions may be related, but it is important to be able to distinguish which of the two you are experiencing in order for you to receive prompt and proper medical treatment as they are two separate conditions.

article thumbnail

5 Key Sessions, Interviews at 2022 ATOPP Summit

Pharmacy Times

Pharmacy Times will be covering the 2022 ATOPP Summit live in San Diego, CA.

122
122
article thumbnail

Warda: The Journey of Fiction and Nonfiction

The Happy PharmD

Warda worked in retail before transitioning to medical writing and novel writing. However, her passion for writing began in pharmacy school when she wrote a full-length novel that she is now attempting to publish. Warda’s difficulties at the pharmacy prompted her to switch to writing full-time. She was subjected to constant stress, a lack of flexibility in her work schedule, a lack of a clear career progression path, and long periods of standing.

article thumbnail

An Overview of the Role of ATOPP in ‘Training the Trainer’ in Oncology Pharmacy

Pharmacy Times

Amy Woodard, PharmD, BCOP, the steering committee co-chair of the 2022 ATOPP Summit, highlights key topics and discussions at the in-person summit in July in San Diego, CA.

65
article thumbnail

From operator to API: how the future of micronisation means no more compromise

Pharmaceutical Technology

Despite industry investment in large molecule drugs, demand for small molecule active pharmaceutical ingredients (API) manufacturing remains high. Driven by the rise of oncology pipeline drugs coupled with small or virtual pharma companies being unable to acquire or access containment capabilities in-house, the increase in high potency small molecule APIs means that the demand for these innovative, specialised capabilities is likely to continue.

52
article thumbnail

Generic Product News: June 2022

Pharmacy Times

This month's product news features acyclovir oral suspension, vigabatrin oral solution, and budesonide and formoterol bumarate dihydrate inhalation aerosol.

65
article thumbnail

Note from the editor: Small but important changes ahead

Outsourcing Pharma

The past two years have been full of shifts and shakes in the drug development field, but the change at Outsourcing-Pharma is easy and one for the better.

52
article thumbnail

5 Key Sessions and Interviews at McKesson ideaShare 2022

Pharmacy Times

Pharmacy Times will be covering McKesson ideaShare 2022 live in Washington, DC, from July 7 through 10.

65
article thumbnail

Introducing Inizio: Ashfield and Huntsworth Unite Expertise to Form Strategic Partner

PharmExec

Inizio will act as a strategic partner to health and life science companies throughout the life cycle of their drug products.

52
article thumbnail

Successful Clinical Outcomes With Treatment in Advanced-Stage Breast Cancer

Pharmacy Times

Heather N. Moore, PharmD, BCOP, CPP, and Susan Faye Dent, MD, FRCPC, FICQS, emphasize the critical role of the pharmacist in achieving clinical endpoints in advanced-stage breast cancer.

65
article thumbnail

ParcelShield Announces Agreement with Walmart Specialty Pharmacy to Expand Services

Pharmaceutical Commerce

ParcelShield Intelligent Tracking and Planning Solution is designed to prevent parcel delays before shipping.

article thumbnail

Case Studies: June 2022

Pharmacy Times

How would you respond to these patients questions?

65
article thumbnail

Inizio, a New Healthcare Communications Company, Launches

Pharmaceutical Commerce

Private-equity-funded conglomerate will offer life sciences commercialization services.

article thumbnail

Atos opens Life Science Centre of Excellence

Pharma Times

Centre will accelerate drug development and enable precision health solutions

50
article thumbnail

Introducing AllianceRx Walgreens Pharmacy

Pharmaceutical Commerce

Specialty and home delivery pharmacy updates name, commits to prioritizing patients.

52
article thumbnail

Sirana enters into collaborative research agreement with Pfizer

Pharma Times

Companies will combine to investigate a novel treatment for a rare bone disease

37